By Ron Sills M.S., Nerac Analyst,
Originally Published: July 6th, 2015
This article describes how medical device manufacturers can and should protect their products and business interests through patent protection. This includes not only patent protection of their own intellectual property, but actively monitoring the industry to ensure there is no infringement on their intellectual property.
Read More
Patent Infringement – Electronics Packaging
Client engaged Nerac for a patent infringement study and risk assessment of packaging materials.
Nutraceutical IP and Regulatory Claims
Originally published September, 2008
Food makers increasingly rely on patented technologies to improve functionality, but strict regulations hamper marketing benefits.
Read more
3D Printing: Legal Landscape and Future Challenges
Originally published January, 2014
Although the future promise of 3D printing, also referred to as additive manufacturing (AM), has been recently promoted for its promise of reduced costs and production times, as well as an increased complexity of integral components, the legal framework is far from clear. Read more
Patent Valuation: Unlocking the Monetary Value of Intellectual Property
Watch the webcast here!
Patent Landscape: Applications in Business and Technical Due Diligence
Watch the webcast here!
Patent Fundamentals for the Innovative Organization
Watch the webcast here!
Nucleic and Amino Acid Sequence Research in an Intellectual Property Management Strategy
The global market for biotechnology represents a large and complex amalgamation of different products that touches many different industry segments. In the healthcare industry alone, biologics represent a greater than $125 billion global market, and biosimilars legislation in the US and EU has spawned new generic biologics markets that will continue to grow. In addition, the even larger and more rapidly growing market for personalized medicine is driving biotechnology-based diagnostic and health management tools. In the agricultural industries, the market for genetically modified seeds and crops that are pest and disease resistant continues to grow. In the energy industries, large rounds of funding continue to drive the development of biofuels, the quality and production of which is likely to be improved by biotechnological advances. Participants in all of these markets rely on positive innovations and intellectual property (IP) rights to maintain and grow their market shares.Read more